The cancer pain related factors affected by celecoxib together with cetuximab in head and neck squamous cell carcinoma

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Yaqiong YangHong Jiang

Abstract

Pain is the most disruptive influence on the quality of prognosis among head and neck squamous cell carcinoma (HNSCC) patients. The development of pain is closely associated with tumor growth and inflammation in the cancer patients. Notably, cyclooxygenase-2 (COX-2) is an important mediator during inflammation. Celecoxib, a selective inhibitor of COX-2, was hailed as a promising chemopreventive agent for HNSCC. Dose-dependent cardiac toxicity limits long-term use of celecoxib. However, the toxicity can be diminished by lowering the dosage. In this study, we hypothesized that a combinatory strategy to reduce cancer pain via two distinct pathways, tumor grown inhibition and inflammation blockade, which would enhance analgesia effect induced by HNSCC. We found that treatment of cetuximab (C225), a monoclonal anti-epidermal growth factor receptor (EGFR) antibody, with low-dose celecoxib results in a more pronounced anticancer effect in HNSCC than either agent alone. More noticeably, the combination could downregulate the phosphorylation of constitutively active extracellular signal regulated kinase (ERK) in CAL-27 and Fadu cells. Furthermore, combination therapy enhancing S phase arrest and downregulating cyclin D1 was observed in ...Continue Reading

References

Mar 29, 1996·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·S B McMahon
Oct 10, 1996·The New England Journal of Medicine·M H Levy
Apr 26, 2000·BJU International·J B Nelson, M A Carducci
Nov 4, 2000·Current Review of Pain·F J Alvarez, R E Fyffe
Feb 13, 2001·The Journal of Clinical Investigation·J L StockL P Audoly
Jul 31, 2001·International Journal of Cancer. Journal International Du Cancer·N KunduA M Fulton
Mar 22, 2002·The Lancet Oncology·A J DannenbergK Subbaramaiah
May 7, 2002·Nature Reviews. Cancer·Patrick W MantyhSteve P Hunt
Dec 3, 2003·The New England Journal of Medicine·Arlene A ForastiereJay Cooper
Apr 23, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·G Davar
Jan 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J DannenbergRaymond N DuBois
Sep 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lori J WirthMarshall R Posner
Jun 3, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karen L ReckampRobert A Figlin
Sep 1, 2006·The New England Journal of Medicine·Nadir ArberUNKNOWN PreSAP Trial Investigators
Oct 6, 2006·American Journal of Clinical Pathology·Federica PerroneSilvana Pilotti
May 26, 2007·Journal of Dental Research·J B EpsteinR Benoliel
Aug 1, 2007·European Journal of Pain : EJP·Victoria PickeringBrian L Schmidt
Mar 8, 2008·The International Journal of Biochemistry & Cell Biology·Anna Bagnato, Laura Rosanò
Jun 12, 2010·Molecular Interventions·Brian L SchmidtGeorge L Wilcox
Jul 14, 2011·Molecular Cancer Therapeutics·Yi YeBrian L Schmidt

❮ Previous
Next ❯

Citations

Jun 19, 2016·Biochimica Et Biophysica Acta·Natalia AlonsoCarina Shayo
Mar 9, 2021·Head & Neck·Constanza Saka-HerránJosé López-López
Jun 17, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shuangshuang LiShuwen Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.